SCHEMBL3467958

SCHEMBL3467958

C=CC(=O)CC=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL175817 0.71
SCHEMBL536652 0.69
SCHEMBL9812717 0.69
Ammonia Solution, Strong SCHEMBL7801535 0.67
SCHEMBL253538 0.67
SCHEMBL28724574 0.67
SCHEMBL31094446 0.67
SCHEMBL29647937 0.67
SCHEMBL3422186 0.67
SCHEMBL3458381 0.67 ALDH1A1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100227522-A1 IMITATING NATURAL PLANT FIBER, PREPARATION METHOD THEREOF AND FABRIC MADE OF IT NOVEKO TRADING 2008 LLC (HU) 2010-09-09 US disclosed
US-6720337-B2 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative N-GENE RESEARCH LABORATORIES, INC. 2004-04-13 US disclosed
US-6656955-B2 Side effect reduction; synergistic mixture N-GENE RESEARCH LABORATORIES, INC. 2003-12-02 US disclosed
US-6440998-B1 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative N-GENE RESEARCH LABORATORIES, INC. 2002-08-27 US disclosed